Understanding how new tobacco products affect smoking habits and health over time
Modeling the Impact of Novel Tobacco Product use on Smoking and Long-Term Health Outcomes
This study looks at how using new tobacco products like e-cigarettes and heated tobacco affects health over time, especially for people who also smoke regular cigarettes or cigars, to help make better rules for keeping everyone safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10932113 on NIH RePORTER |
What this research studies
This research investigates the long-term health impacts of using novel tobacco products, such as electronic nicotine delivery systems and heated tobacco products, alongside traditional cigarettes and cigars. By analyzing data from national health surveys and existing literature, the study aims to identify patterns of tobacco use and transitions between different products. The findings will help inform regulatory actions by the FDA to protect public health and guide future tobacco control policies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who use or have used various tobacco products, including cigarettes, cigars, and electronic nicotine delivery systems.
Not a fit: Patients who do not use tobacco products or have never been exposed to tobacco may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved public health policies that reduce tobacco-related health risks.
How similar studies have performed: Previous research has successfully utilized similar modeling approaches to assess tobacco use patterns and health outcomes, indicating a promising avenue for this study.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Levy, David Theodore — University of Michigan at Ann Arbor
- Study coordinator: Levy, David Theodore
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.